(Q35860206)

10 August 2017

1 reference

title

Practical difficulties in the management of hepatitis B in the Asia-Pacific region (English)

1 reference

10 August 2017

1 reference

15

Teerha Piratvisuth

1 reference

10 August 2017

12

Seng Gee Lim

1 reference

10 August 2017

Rosmawati Mohamed

1

1 reference

10 August 2017

Paul Desmond

2

1 reference

10 August 2017

Dong-Jin Suh

3

1 reference

10 August 2017

Deepak Amarapurkar

4

1 reference

10 August 2017

Edward Gane

5

1 reference

10 August 2017

Yao Guangbi

6

1 reference

10 August 2017

Jin-Lin Hou

7

1 reference

10 August 2017

Wasim Jafri

8

1 reference

10 August 2017

Ching Lung Lai

9

1 reference

10 August 2017

Chang-Hong Lee

10

1 reference

10 August 2017

Shou-Dong Lee

11

1 reference

10 August 2017

Richard Guan

13

1 reference

10 August 2017

Pham Hoang Phiet

14

1 reference

10 August 2017

Jose Sollano

16

1 reference

10 August 2017

Jaw-Ching Wu

17

1 reference

10 August 2017

language of work or name

1 reference

1 September 2004

1 reference

Journal of Gastroenterology and Hepatology

10 August 2017

published in

1 reference

10 August 2017

volume

19

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

958-969

1 reference

The discovery of the hepatitis viruses

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Chronic hepatitis B virus infection in Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Economic evaluation of the societal costs of hepatitis B in South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Hepatitis B epidemiology in Asia, the Middle East and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Diagnosis and management of pre-core mutant chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Global control of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Prevention and control of hepatitis B in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Histological outcome during long-term lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Molecular Epidemiology of Hepatitis B Viral Serotypes and Genotypes in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

Impact of hepatitis B immunisation as part of the EPI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03420.X

10.1111/J.1440-1746.2004.03420.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference